Medication algorithms for schizophrenia
- 作者A.L. Miller; J.A. Chiles; A.J. Rush; M.L. Crismon; M.G. Toprac; K.L. Shores-Wilson
- 卷第29卷
- 文件大小94.29KB
- 发表时间1998
- DOI10.1016/s0920-9964(97)88710-5
Further evidence for an association between the Xbal polymorphism at the apolipoprotein B locus and lipoprotein levelTrond P. Leren; Kåre Berg; Ingvar Hjermann; Paul Leren · 1988
Further evidence for the association between 5-HT2Creceptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patientsArzu Gunes; Marja-Liisa Dahl; Edoardo Spina; Maria Gabriella Scordo · 2008
Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1and ADHD: findings from a sample of adultsde Azeredo, Lucas A.; Rovaris, Diego L.; Mota, Nina R.; Polina, Evelise R.; Marques, Francine Z.; Contini, Verônica; Vitola, Eduardo S.; Belmonte-de-Abreu, Paulo; Rohde, Luis A.; Grevet, Eugenio H.; Bau, Claiton H. D. · European Archives of Psychiatry and Clinical Neuroscience · 2014
Erratum to: Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1and ADHD: findings from a sample of adultsde Azeredo, Lucas A.; Rovaris, Diego L.; Mota, Nina R.; Polina, Evelise R.; Marques, Francine Z.; Contini, Verônica; Vitola, Eduardo S.; Belmonte-de-Abreu, Paulo; Rohde, Luis A.; Grevet, Eugenio H.; Bau, Claiton H. D. · European Archives of Psychiatry and Clinical Neuroscience · 2016